GFR Assessment of Living Kidney Donors Candidates

被引:13
作者
Gaillard, Francois [1 ,2 ]
Legendre, Christophe [1 ,2 ]
White, Christine A. [3 ]
机构
[1] Hop Necker Enfants Malad, AP HP, Renal Transplantat Dept, Paris, France
[2] Paris Descartes Univ, Paris, France
[3] Queens Univ, Dept Med, Kingston, ON, Canada
关键词
GLOMERULAR-FILTRATION-RATE; SHRUNKEN PORE SYNDROME; BETA-TRACE PROTEIN; SERUM CYSTATIN C; QUALITY-OF-LIFE; PLASMA-CLEARANCE; RENAL-FUNCTION; CREATININE; PERFORMANCE; EQUATIONS;
D O I
10.1097/TP.0000000000002620
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Living kidney donation provides the best outcomes (survival, cost, and quality of life) of all renal replacement modalities. Living kidney donors, on the other hand, are at the increased risk of end-stage kidney disease (ESKD) after donation compared with healthy nondonors for multiple possible reasons. Extensive predonation screening is required to assess eligibility for donation to avoid the rejection of suitable candidates and minimize acceptance of donors with increased risk of ESKD. The association between the lower predonation glomerular filtration rate (GFR) and increased ESKD risk in donors highlights the relevance of GFR assessment for living kidney donor candidates. However, the method to evaluate GFR is still debated, and the thresholds of acceptable predonation GFR vary across guidelines. All guidelines favor GFR measurement with an exogenous tracer over estimated GFR, but only the British Transplant Society guidelines mandates it. While the Kidney Disease Improving Global Outcomes Group guidelines advocates for age-independent GFR thresholds, most other guidelines propose various age-dependent GFR thresholds with resulting profound differences in assessment of donor suitability between guidelines. Many important questions are not addressed by any guidelines, including the approach to discordant GFR measurement and estimated GFR results, the use of method-specific GFR thresholds and thresholds dependent on comorbidities or race. Further data are required exploring the associations between these variables and the course of postdonation GFR. Last, GFR evaluation studies conducted in approved donors and not in those initially presenting as potential candidates are questionable regarding their suitability for potential donor evaluation.
引用
收藏
页码:1086 / 1093
页数:8
相关论文
共 74 条
  • [1] Assessment of Iothalamate Plasma Clearance: Duration of Study Affects Quality of GFR
    Agarwal, Rajiv
    Bills, Jennifer E.
    Yigazu, Paulos M.
    Abraham, Terri
    Gizaw, Andinet B.
    Light, Robert P.
    Bekele, Dagim. M.
    Tegegne, Getachew G.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (01): : 77 - 85
  • [2] [Anonymous], 2018, United States Renal Data System
  • [3] [Anonymous], 2016, J AM SOC NEPHROL
  • [4] [Anonymous], PROIN SERB 25 SOL IN
  • [5] [Anonymous], 2016, REP CORR 2016
  • [6] [Anonymous], ORG PROC TRANSPL NET
  • [7] [Anonymous], KIDNEY INT
  • [8] [Anonymous], RAPP REIN 2016
  • [9] [Anonymous], SYST PROGR REP 2006
  • [10] [Anonymous], J AM SOC NEPHROL